Share

Search your stocks

Ctrl+K

ARISTOAristo Bio-Tech and Lifescience Ltd.

130.1(+0.00%)

1W: -5.72%

1M: +10.07%

1Y: +94.18%

Aristo Bio-Tech and Lifescience Quarterly Results

Pros & Cons

POSITIVES

Revenue continues to show a steady upward trend, reflecting strong demand for products in the biotech sector.
Gross margins improved, indicating better cost management and pricing strategies.
Positive developments in R&D have led to promising new product launches, enhancing future growth prospects.

NEGATIVES

Sales growth has slowed down compared to previous quarters, indicating potential market saturation.
Operating expenses increased significantly, eroding profit margins and affecting net income.
Cash flow from operations is declining, raising concerns over liquidity and financial stability.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-